Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Shares Outstanding (Weighted Average) (2016 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Shares Outstanding (Weighted Average) for 13 consecutive years, with $67.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding (Weighted Average) rose 3.62% year-over-year to $67.7 million, compared with a TTM value of $67.7 million through Sep 2025, up 3.62%, and an annual FY2024 reading of $65.9 million, up 1.49% over the prior year.
  • Shares Outstanding (Weighted Average) was $67.7 million for Q3 2025 at Tandem Diabetes Care, up from $67.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $67.7 million in Q3 2025 and bottomed at $62.4 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $64.7 million, with a median of $64.7 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Weighted Average) increased 4.53% in 2021, then rose 0.26% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $63.0 million in 2021, then increased by 1.82% to $64.1 million in 2022, then increased by 1.28% to $65.0 million in 2023, then increased by 1.49% to $65.9 million in 2024, then rose by 2.6% to $67.7 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for TNDM at $67.7 million in Q3 2025, $67.0 million in Q2 2025, and $66.4 million in Q1 2025.